Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $140000.0.

  • Anaptysbio's Depreciation & Amortization (CF) fell 277.78% to $140000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $573000.0, marking a year-over-year decrease of 846.65%. This contributed to the annual value of $606000.0 for FY2024, which is 705.52% down from last year.
  • Per Anaptysbio's latest filing, its Depreciation & Amortization (CF) stood at $140000.0 for Q3 2025, which was down 277.78% from $142000.0 recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Depreciation & Amortization (CF) registered a high of $184000.0 during Q4 2022, and its lowest value of $125000.0 during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $162000.0 (2022), whereas its average is $156842.1.
  • In the last 5 years, Anaptysbio's Depreciation & Amortization (CF) skyrocketed by 2960.0% in 2022 and then plummeted by 1212.12% in 2024.
  • Quarter analysis of 5 years shows Anaptysbio's Depreciation & Amortization (CF) stood at $165000.0 in 2021, then grew by 11.52% to $184000.0 in 2022, then dropped by 10.33% to $165000.0 in 2023, then decreased by 12.12% to $145000.0 in 2024, then fell by 3.45% to $140000.0 in 2025.
  • Its last three reported values are $140000.0 in Q3 2025, $142000.0 for Q2 2025, and $146000.0 during Q1 2025.